Efficacy of Imidazole Antifungal Agents in the Treatment of Nras and Braf Mutant Human Melanoma Cells

被引：0
|
作者：
Koh, David [1 ]
Jira, Lukas R. [1 ]
Foster, Hattie M. [1 ]
Carle, McKenzie N. [1 ]
Hall, Hannah K. [1 ]
Sutherland, Maxwell A. [1 ]
机构：
[1] Ohio Northern Univ, Coll Pharm, Ada, OH USA
来源：
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 2023年 / 385卷
关键词：
D O I：
10.1124/jpet.122.196240
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
241
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Harnessing NK cells to improve targeted therapy therapeutic efficacy in BRAF- mutant melanoma
    Hsu, Chia-Hsin
    White, Andrew C.
    CANCER RESEARCH, 2024, 84 (22)
  • [32] Characterization of Drug Resistance Protein Expression Levels in Human Melanoma Cells and Subsequent Treatment with Antifungal Agents
    Koh, David W.
    McKamey, Shelby G.
    Daghistani, Ayah T.
    Jira, Lukas R.
    Blake, Steven D.
    FASEB JOURNAL, 2018, 32 (01):
  • [33] Sequential treatment with immunotherapy and BRAF inhibitors in BRAF-mutant advanced melanoma
    Aya, F.
    Fernandez-Martinez, A.
    Gaba, L.
    Victoria, I.
    Tosca, M.
    Pineda, E.
    Gascon, P.
    Prat, A.
    Arance, A.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (01): : 119 - 124
  • [34] Sequential treatment with immunotherapy and BRAF inhibitors in BRAF-mutant advanced melanoma
    F. Aya
    A. Fernandez-Martinez
    L. Gaba
    I. Victoria
    M. Tosca
    E. Pineda
    P. Gascon
    A. Prat
    A. Arance
    Clinical and Translational Oncology, 2017, 19 : 119 - 124
  • [35] Phosphoproteomic analysis of basal and therapy-induced adaptive signaling networks in BRAF and NRAS mutant melanoma
    Fedorenko, Inna V.
    Fang, Bin
    Munko, Ana Cecelia
    Gibney, Geoffrey T.
    Koomen, John M.
    Smalley, Keiran S. M.
    PROTEOMICS, 2015, 15 (2-3) : 327 - 339
  • [36] Prenylation inhibition induces cell death in NRAS mutant melanoma cells
    Garay, Tamas
    Kenessey, Istvan
    Laszlo, Viktoria
    Tovari, Jozsef
    Berger, Walter
    Kovacs, Laszlo
    Timar, Jozsef
    Hegedus, Balazs
    MOLECULAR CANCER RESEARCH, 2014, 12
  • [37] Combination with γ-secretase inhibitor prolongs treatment efficacy of BRAF inhibitor in BRAF-mutated melanoma cells
    Schrama, D.
    Zhu, G.
    Goebeler, M.
    Houben, R.
    EXPERIMENTAL DERMATOLOGY, 2017, 26 (03) : E93 - E93
  • [38] Combination with γ-secretase inhibitor prolongs treatment efficacy of BRAF inhibitor in BRAF-mutated melanoma cells
    Zhu, Guannan
    Yi, Xiuli
    Haferkamp, Sebastian
    Hesbacher, Sonja
    Li, Chunying
    Goebeler, Matthias
    Gao, Tianwen
    Houben, Roland
    Schrama, David
    CANCER LETTERS, 2016, 376 (01) : 43 - 52
  • [39] Combination with γ-secretase inhibitor prolongs treatment efficacy of BRAF inhibitor in BRAF-mutated melanoma cells
    Schrama, D.
    Zhu, G.
    Goebeler, M.
    Houben, R.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 : 26 - 27
  • [40] Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma
    Wong, Deborah J. L.
    Robert, Lidia
    Atefi, Mohammad S.
    Lassen, Amanda
    Avarappatt, Geetha
    Cerniglia, Michael
    Avramis, Earl
    Tsoi, Jennifer
    Foulad, David
    Graeber, Thomas G.
    Comin-Anduix, Begonya
    Samatar, Ahmed
    Lo, Roger S.
    Ribas, Antoni
    MOLECULAR CANCER, 2014, 13
12345